vs
Side-by-side financial comparison of TIDEWATER INC (TDW) and Bio-Techne (TECH). Click either name above to swap in a different company.
TIDEWATER INC is the larger business by last-quarter revenue ($336.8M vs $311.4M, roughly 1.1× Bio-Techne). TIDEWATER INC runs the higher net margin — 65.3% vs 16.4%, a 48.9% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-1.5% vs -2.4%). Over the past eight quarters, TIDEWATER INC's revenue compounded faster (2.4% CAGR vs 1.3%).
Tidewater, Inc. is a publicly traded international petroleum service company headquartered in Houston, Texas, U.S. It operates a fleet of ships, primarily providing vessels and marine services to the offshore petroleum and offshore wind industries.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
TDW vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $336.8M | $311.4M |
| Net Profit | $219.9M | $51.0M |
| Gross Margin | — | 66.9% |
| Operating Margin | 19.0% | 24.2% |
| Net Margin | 65.3% | 16.4% |
| Revenue YoY | -2.4% | -1.5% |
| Net Profit YoY | 495.8% | 126.0% |
| EPS (diluted) | $4.37 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | $336.8M | $295.9M | ||
| Q3 25 | $341.1M | — | ||
| Q2 25 | $341.4M | $317.0M | ||
| Q1 25 | $333.4M | $316.2M | ||
| Q4 24 | $345.1M | $297.0M | ||
| Q3 24 | $340.4M | $289.5M | ||
| Q2 24 | $339.2M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | $219.9M | $38.0M | ||
| Q3 25 | $-806.0K | — | ||
| Q2 25 | $72.9M | $-17.7M | ||
| Q1 25 | $42.7M | $22.6M | ||
| Q4 24 | $36.9M | $34.9M | ||
| Q3 24 | $46.4M | $33.6M | ||
| Q2 24 | $50.4M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 19.0% | 18.4% | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 23.7% | -7.5% | ||
| Q1 25 | 22.5% | 12.2% | ||
| Q4 24 | 23.6% | 16.0% | ||
| Q3 24 | 20.6% | 13.8% | ||
| Q2 24 | 23.0% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | 65.3% | 12.8% | ||
| Q3 25 | -0.2% | — | ||
| Q2 25 | 21.4% | -5.6% | ||
| Q1 25 | 12.8% | 7.1% | ||
| Q4 24 | 10.7% | 11.7% | ||
| Q3 24 | 13.6% | 11.6% | ||
| Q2 24 | 14.8% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $4.37 | $0.24 | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $1.46 | $-0.11 | ||
| Q1 25 | $0.83 | $0.14 | ||
| Q4 24 | $0.70 | $0.22 | ||
| Q3 24 | $0.87 | $0.21 | ||
| Q2 24 | $0.94 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $578.8M | $209.8M |
| Total DebtLower is stronger | $670.1M | — |
| Stockholders' EquityBook value | $1.4B | $2.1B |
| Total Assets | $2.4B | $2.6B |
| Debt / EquityLower = less leverage | 0.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $578.8M | $172.9M | ||
| Q3 25 | $428.2M | — | ||
| Q2 25 | $369.4M | $162.2M | ||
| Q1 25 | $341.8M | $140.7M | ||
| Q4 24 | $324.9M | $177.5M | ||
| Q3 24 | $280.8M | $187.5M | ||
| Q2 24 | $315.9M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $670.1M | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $647.9M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.1B | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.4B | $2.5B | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $2.0B | $2.7B | ||
| Q2 24 | $2.1B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.49× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.58× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $153.0M | — |
| Free Cash FlowOCF − Capex | $147.8M | — |
| FCF MarginFCF / Revenue | 43.9% | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | 0.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $353.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $153.0M | — | ||
| Q3 25 | $54.7M | — | ||
| Q2 25 | $85.4M | $98.2M | ||
| Q1 25 | $86.0M | $41.1M | ||
| Q4 24 | $100.0M | $84.3M | ||
| Q3 24 | $49.0M | $63.9M | ||
| Q2 24 | $78.6M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | $147.8M | — | ||
| Q3 25 | $49.6M | — | ||
| Q2 25 | $80.2M | $93.3M | ||
| Q1 25 | $75.7M | $31.0M | ||
| Q4 24 | $95.5M | $77.5M | ||
| Q3 24 | $43.3M | $54.7M | ||
| Q2 24 | $72.3M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | 43.9% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 23.5% | 29.4% | ||
| Q1 25 | 22.7% | 9.8% | ||
| Q4 24 | 27.7% | 26.1% | ||
| Q3 24 | 12.7% | 18.9% | ||
| Q2 24 | 21.3% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.5% | 1.5% | ||
| Q1 25 | 3.1% | 3.2% | ||
| Q4 24 | 1.3% | 2.3% | ||
| Q3 24 | 1.7% | 3.2% | ||
| Q2 24 | 1.9% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 2.02× | 1.82× | ||
| Q4 24 | 2.71× | 2.42× | ||
| Q3 24 | 1.06× | 1.90× | ||
| Q2 24 | 1.56× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TDW
Segment breakdown not available.
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
